Drug
Drotrecogin alfa activated clinical trials
Also written Drotrecogin alfa (activated), Xigris and LY203638.
How studies write it
Studies that test it under each name
Studies by the year they started
16 studies that test it; most in 2002 (4)
| Year | Studies |
|---|---|
| 2002 | 4 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 5
Eli Lilly and Company (11) · George Washington University (1) · Central Hospital, Nancy, France (1) · Helsinki University Central Hospital (1) · University of Rochester (1) · University of California, San Francisco (1)
Studies
Open first, then newest update. How each study uses drotrecogin alfa activated is read from its arms, and is right about nine times in ten.
Testing it · 16
- Safety and Dose Finding Study of Xigris in Hemodialysis PatientsCompletedPhase 2George Washington UniversityNCT01227187Written as Drotrecogin alfa activated (Xigris)
- Activated Protein C in Acute Stroke TrialTerminatedPhase 2University of RochesterNCT00533546Written as Activated Protein C
- Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein CCompletedPhase 4Central Hospital, Nancy, FranceNCT02885168Written as Recombinant Activated Protein C
- Activated Protein C to Treat Acute Lung InjuriesTerminatedPhase 2University of California, San FranciscoNCT00112164Written as Xigris
- Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic ShockCompletedPhase 3Eli Lilly and CompanyNCT00604214Written as Drotrecogin alfa (activated)
- Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)CompletedPhase 2Eli Lilly and CompanyNCT00386425Written as Drotrecogin alfa (activated)
- Activated Protein C in Severe Acute PancreatitisCompletedPhase 4Helsinki University Central HospitalNCT01017107Written as Activated protein C
- Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic ShockCompletedPhase 4Eli Lilly and CompanyNCT00279214Written as drotrecogin alfa (activated)
- Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory StudyCompletedPhase 2Eli Lilly and CompanyNCT00191724Written as Drotrecogin Alfa (Activated)
- A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow TransplantationCompletedPhase 4Eli Lilly and CompanyNCT00067730Written as Drotrecogin Alfa (activated)
- The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of DeathCompletedPhase 3Eli Lilly and CompanyNCT00568737Written as Drotrecogin alfa (activated)
- An Open Label Study of Severe Sepsis in AdultsCompletedPhase 4Eli Lilly and CompanyNCT00568893Written as drotrecogin alfa (activated)
- Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe SepsisCompletedPhase 3Eli Lilly and CompanyNCT00049764Written as Drotrecogin alfa (activated)
- Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days InfusionCompletedPhase 3Eli Lilly and CompanyNCT00190788Written as Drotrecogin Alfa (Activated)
- A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)CompletedPhase 4Eli Lilly and CompanyNCT00049777Written as Drotrecogin Alfa (Activated)
- The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe SepsisCompletedPhase 4Eli Lilly and CompanyNCT00045760Written as Drotrecogin alfa (activated)
As the comparator · 1 — what is tested is compared with drotrecogin alfa activated
Codes
What other systems call drotrecogin alfa activated · ClinicalTrials.gg INT004312
- MeSH (NLM) C421124drotrecogin alfa activatedConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JGH8MYC891DROTRECOGIN ALFA (ACTIVATED)Confirmed FDA, NLM, Wikidata
- RxNorm 353106Confirmed FDA, Wikidata
- Wikidata Q412888drotrecogin alfaConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C80267Drotrecogin Alfa (Activated)Confirmed FDA, Wikidata
- DrugBank DB00055One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C421124 | drotrecogin alfa activated | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JGH8MYC891 | DROTRECOGIN ALFA (ACTIVATED) | Confirmed FDA, NLM, Wikidata |
| RxNorm | 353106 | — | Confirmed FDA, Wikidata |
| Wikidata | Q412888 | drotrecogin alfa | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C80267 | Drotrecogin Alfa (Activated) | Confirmed FDA, Wikidata |
| DrugBank | DB00055 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.